ABOUT US RESEARCH PRODUCTS CAREERS HOME INVESTORS NEWSROOM LICENSING CONTACT US QUICK LINKS VIEWS AND POSITIONS About Us Our Values Corporate Responsibility Health Tips & Resources Leadership How We Operate Views and Positions Our History Featured Stories We support public policies that advance the interests of patients, improve public health and promote access to medicines and innovation. We work to achieve our business objectives responsibly and respond to our many stakeholders' needs and concerns. We support policies that promote the discovery of innovative medicines and vaccines and make these products available to all who need them. To advance this objective, we: develop policy positions that guide our activities and advocacy on a range of issues; seek opportunities to adopt industry-leading standards in several areas; strive to communicate clearly and transparently about our positions; and work closely with the many groups and individuals who are also trying to address the complex healthcare challenges that confront us. Corporate Political Contributions and Merck Political Action Committee Merck is committed to participating constructively in the political process. Government proposals to regulate the health care system may directly affect the Company's business and incentives for pharmaceutical innovation. Also, there are important policy initiatives that can further the company's goals with respect to increasing patient access to medicines and vaccines, and most importantly, to health care insurance coverage. It is appropriate for the Company to help inform the debate on these issues in the United States and in other countries. The primary means by which Merck engages in this debate is by communicating information to government officials. In the United States, Canada and Australia, the Company also provides corporate political contributions, primarily to the electoral campaigns of individual candidates. Learn more PRINT SHARE SIZE CORPORATE RESPONSIBILITY View the full report View the 2013 Executive Summary PUBLIC POLICY POSITION STATEMENTS View the list of statements ACCESS & AFFORDABILITY Charitable Product Donations Intellectual Property and Access to Medicines in the Developing World Statement of Guiding Principles on Access to Health Medicare Compulsory Licensing Regulatory Data Protection Social Licensing Approach for Research Development Partnerships for Neglected Tropical Diseases (NTDs) Medicines Patent Pool IMPLANON® Family Planning Statement IMPLANON® Access Initiative for Low-Income Countries ISENTRESS® in Low-Income Countries INNOVATION Establishing Effective Systems for Early Resolution of IP Disputes in Pharmaceuticals Patent Term Extensions Health Technology Assessment and Comparative Effectiveness Research PUBLIC HEALTH ISSUES Antimicrobial Resistance Biosimilars and Originator Biologics Climate Change Counterfeiting Nanotechnology Pharmaceuticals in the Environment Responsible Disposal of Medicines Water TRANSPARENCY & RESPONSIBLE BEHAVIOR Human Rights Independent Expenditures Direct-to-Consumer Advertising Trade Association Memberships (Merck) Transparency Disclosures Clinical Trial Ethics Clinical Trials Data Disclosure Conflict Minerals RELATED INFORMATION Trade association memberships (Merck) Transparency Disclosures Copyright © 2009-2014 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved. Privacy Terms of Use Site Map